Horizon Therapeutics
Horizon Therapeutics, now acquired by Amgen, is a global biopharmaceutical company headquartered in Dublin, Ireland, with a focus on rare, autoimmune, and severe inflammatory diseases.
Company Overview
Horizon Therapeutics focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. They have a global presence with offices in North America, Europe, Asia, and South America. Their global headquarters is located in Dublin, Ireland, with their U.S. headquarters situated in Deerfield, Illinois.
Global Presence
Horizon Therapeutics operates on a worldwide scale, with offices located across multiple continents. They have a significant presence in North America with offices in Canada and multiple locations in the United States including California, the District of Columbia, Illinois, and Maryland. In Europe, they have offices in Germany, Ireland, Italy, and Switzerland. They also have a strong presence in Asia with an office in Tokyo, Japan, and in South America with an office in Sao Paulo, Brazil.
Named Patient Use Programs
Horizon Therapeutics offers Named Patient Use Programs for two of its key products, TEPEZZA® (teprotumumab-trbw) and UPLIZNA® (inebilizumab-cdon), in partnership with WEP Clinical. TEPEZZA is approved by the United States Food and Drug Administration (FDA) for the treatment of Thyroid Eye Disease (TED). UPLIZNA is approved in the United States, Japan, and South Korea for the treatment of adults with anti-aquaporin-4 antibody positive (AQP4-IgG+) Neuromyelitis Optica Spectrum Disorder (NMOSD).
Acquisition by Amgen
Horizon Therapeutics has been acquired by Amgen. This acquisition integrates Horizon's portfolio of treatments targeting rare, autoimmune, and severe inflammatory diseases with Amgen's extensive resources and capabilities.
Headquarters
Horizon Therapeutics' global headquarters is located in Dublin, Ireland. The U.S. headquarters is sited in Deerfield, Illinois. These strategic locations support their operations and outreach in the biotechnology and pharmaceutical sectors.